Scottish Medicines Consortium (SMC) published advice for andexanet alfa (Ondexxya®) September 2020

The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and, following review by the SMC executive, advises NHS Boards and Area Drug and Therapeutics Committees on its use in NHSScotland.

Download Full Document

Further information: https://www.scottishmedicines.org.uk/